Nuveen Asset Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$11.1M Sell
220,679
-1,401
-0.6% -$70.6K ﹤0.01% 1538
2024
Q3
$10.3M Sell
222,080
-1,285
-0.6% -$59.5K ﹤0.01% 1584
2024
Q2
$7.26M Buy
223,365
+4,328
+2% +$141K ﹤0.01% 1757
2024
Q1
$5.52M Sell
219,037
-44,354
-17% -$1.12M ﹤0.01% 1939
2023
Q4
$8.55M Buy
263,391
+5,011
+2% +$163K ﹤0.01% 1695
2023
Q3
$7.04M Sell
258,380
-20,266
-7% -$552K ﹤0.01% 1684
2023
Q2
$6.2M Buy
278,646
+31,594
+13% +$703K ﹤0.01% 1788
2023
Q1
$5.35M Sell
247,052
-7,006
-3% -$152K ﹤0.01% 1848
2022
Q4
$5.16M Sell
254,058
-8,986
-3% -$183K ﹤0.01% 1888
2022
Q3
$6.74M Sell
263,044
-162,954
-38% -$4.18M ﹤0.01% 1714
2022
Q2
$10.1M Buy
425,998
+72,237
+20% +$1.72M ﹤0.01% 1503
2022
Q1
$8.71M Buy
353,761
+65,122
+23% +$1.6M ﹤0.01% 1738
2021
Q4
$5.58M Sell
288,639
-51,520
-15% -$996K ﹤0.01% 2050
2021
Q3
$6.7M Sell
340,159
-42,776
-11% -$842K ﹤0.01% 2060
2021
Q2
$8.43M Sell
382,935
-57,467
-13% -$1.26M ﹤0.01% 1973
2021
Q1
$10.5M Buy
440,402
+2,314
+0.5% +$55K ﹤0.01% 1768
2020
Q4
$11.5M Buy
438,088
+410
+0.1% +$10.7K ﹤0.01% 1620
2020
Q3
$7.62M Sell
437,678
-209,925
-32% -$3.65M ﹤0.01% 1682
2020
Q2
$10.9M Buy
647,603
+4,468
+0.7% +$75.2K ﹤0.01% 1428
2020
Q1
$7.65M Buy
643,135
+187,239
+41% +$2.23M ﹤0.01% 1458
2019
Q4
$5.52M Sell
455,896
-62,262
-12% -$753K ﹤0.01% 1939
2019
Q3
$7.32M Sell
518,158
-4,620
-0.9% -$65.3K ﹤0.01% 1752
2019
Q2
$5.83M Buy
+522,778
New +$5.83M ﹤0.01% 1892